Disparities in magnetic resonance imaging of the prostate for traditionally underserved patients with prostate cancer.

ABSTRACT:

Background

Prebiopsy magnetic resonance imaging (MRI) of the prostate improves detection of significant tumors, while decreasing detection of less-aggressive tumors. Therefore, its use has been increasing over time. In this study, the use of prebiopsy MRI among Medicare beneficiaries with prostate cancer was examined. It was hypothesized that patients of color and those in isolated areas would be less likely to undergo this approach for cancer detection.

Methods

Using cancer registry data from the Surveillance, Epidemiology, and End Results (SEER) program linked to billing claims for fee-for-service Medicare beneficiaries, men with nonmetastatic prostate cancer were identified from 2010 through 2015 with prostate-specific antigen (PSA) <30 ng/mL. Outcome was prebiopsy MRI of

SUBMITTER: Quinn TP 

PROVIDER: S-EPMC8319036 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature